Close
Alliance Trust PLC - Net Asset Value May 20, 2024 07:48AM

ALLIANCE TRUST PLC                 At the close of business Friday 17 May 2024:

The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was

-       excluding income, 1277.6p                 -       including income, 1285.3p   The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was

-       excluding income, 1281.5p

-       including... (continue reading...)


Infrared Sauna Use in UCSF Clinical Trial Shows Promise in Combating Depression May 20, 2024 07:45AM

Berkeley, California, May 20, 2024 (GLOBE NEWSWIRE) -- In conjunction with May as Mental Health Awareness Month, preliminary results from a University of California, San Francisco (UCSF) clinical trial combining heat exposure with psychotherapy sessions showed reductions in depression. The study, led by Ashley E. Mason, PhD, a clinical psychologist at the UCSF Osher Center for Integrative Health and the UCSF Weill Institute for Neurosciences, tested an integrated... (continue reading...)


Form 8.3 - AXA INVESTMENT MANAGERS: Darktrace plc May 20, 2024 07:39AM

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser:AXA Investment Managers S.A.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the... (continue reading...)
Form 8.3 - AXA INVESTMENT MANAGERS: Spirent Communications plc May 20, 2024 07:37AM

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE / DEALING BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR   MORE   Rule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser:AXA Investment Managers S.A.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the... (continue reading...)
Alta Equipment Group Announces Proposed Private Offering of $500 Million of Senior Secured Second Lien Notes May 20, 2024 07:35AM

LIVONIA, Mich., May 20, 2024 (GLOBE NEWSWIRE) -- Alta Equipment Group Inc. (NYSE: ALTG) (“Alta” or the “Company”), today announced that it intends to offer, subject to market and other conditions, $500 million in aggregate principal amount of its senior secured second lien notes due 2029 in a private offering (the “offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The notes... (continue reading...)


More Globe Newswire

View Older Stories

May 20, 2024 07:30AM Leading Proxy Advisory Firms Recommend Shareholders Vote “FOR” All of Crown Castle’s Director Nominees
May 20, 2024 07:30AM Agrify Corporation Mutually Agrees to Terminate Plan to Merge with Nature’s Miracle
May 20, 2024 07:30AM Nexxen Reports Results for the First Quarter Ended March 31, 2024
May 20, 2024 07:30AM Reunion Neuroscience Announces Publication of Results from Early Preclinical Studies Demonstrating the Potential of RE104 for Development in Depressive Disorders
May 20, 2024 07:30AM BrightSpring Health Services Announces Onco360® Was Selected as National Pharmacy Partner for OJEMDA™
May 20, 2024 07:30AM SL Green Realty Corp. Announces Common Stock Dividend
May 20, 2024 07:16AM Form 8.3 - Lok'n Store Group PLC
May 20, 2024 07:12AM Form 8.3 - Equals Group PLC
May 20, 2024 07:05AM Mesa Air Group Reports First Quarter Fiscal 2024 Results
May 20, 2024 07:03AM Nicole Robinson Appointed President of DataPath Inc.
May 20, 2024 07:03AM Wugen Announces RMAT and PRIME Designations for WU-CART-007 to Accelerate Regulatory Reviews and Plans to Present Positive Phase 2 Study Findings at European Hematology Association (EHA) 2024 in June
May 20, 2024 07:00AM Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024
May 20, 2024 07:00AM Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024
May 20, 2024 07:00AM Aveanna to Participate at the UBS Healthcare Services Cape Cod Summit and Jefferies Global Healthcare Conference
May 20, 2024 07:00AM Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024
May 20, 2024 07:00AM TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing
May 20, 2024 07:00AM Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale
May 20, 2024 07:00AM Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
May 20, 2024 07:00AM Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference
May 20, 2024 07:00AM Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale
May 20, 2024 07:00AM Sono-Tek Announces Year-End FY 2024 Earnings Conference Call
May 20, 2024 07:00AM Highest Performances Holdings Inc. (NASDAQ: HPH) to Announce Unaudited Financial Results For The First Half of The Fiscal Year 2024 and Host Conference Call on May 30, 2024
May 20, 2024 07:00AM Arqit Quantum Inc. Announces Financial and Operational Results for the First Half of Fiscal Year 2024
May 20, 2024 07:00AM New Campaign from The Trial for #ClinicalEquality – “Worth Less” –Spotlights the Cost of Clinical Inequality
May 20, 2024 07:00AM Global-e Reports First Quarter 2024 Results
May 20, 2024 07:00AM Enlight Announces Participation at Upcoming JP Morgan and Roth MKM Investor Conferences
May 20, 2024 07:00AM Children International Hosts Ecuadorian Students in Kansas City for Global Finals of ‘Destination Imagination’ Tournament
May 20, 2024 07:00AM Vivid Seats to Participate in William Blair’s 2024 Growth Stock Conference
May 20, 2024 07:00AM ECARX Announces First Quarter 2024 Unaudited Financial Results
May 20, 2024 07:00AM Ageas and Taiping deepen cooperation in pension solutions
May 20, 2024 07:00AM At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 Diabetes
May 20, 2024 06:58AM MAOCAT Presale Is Off to a Successful Start, Raising $300K Already
May 20, 2024 06:55AM Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel
May 20, 2024 06:50AM ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
May 20, 2024 06:47AM Bayport Management Ltd announces standstill agreement and is in constructive negotiations with creditors to address its capital structure, cash interest obligations and debt maturities
May 20, 2024 06:45AM Public Entities of America, LLC joins Apex Insurance Agency, LLC, part of Bridge Specialty Group, LLC
May 20, 2024 06:35AM Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting
May 20, 2024 06:30AM Scorpio Tankers Inc. Announces Agreement for a $223.6 Million Prepayment under its 2023 $1.0 Billion Credit Facility
May 20, 2024 06:30AM Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Mu
May 20, 2024 06:30AM Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
May 20, 2024 06:30AM Voyageur Mineral Explorers Corp. Options Alberts Lake Project
May 20, 2024 06:30AM The Board of Directors of Eezy Plc has resolved to change the target levels of the performance criteria for the fourth performance period of the share-based incentive plan for the company's key employ
May 20, 2024 06:23AM HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
May 20, 2024 06:15AM Brunswick Corporation releases 2023 Corporate Sustainability Report
May 20, 2024 06:11AM Resolutions of the Annual General Meeting of Shareholders of Aktsiselts Infortar
May 20, 2024 06:11AM Man Group PLC : Form 8.3 - Redrow plc
May 20, 2024 06:06AM Man Group PLC : Form 8.3 - Barratt Developments plc
May 20, 2024 06:05AM Dimensional Fund Advisors Ltd. : Form 8.3 - TYMAN PLC - Ordinary Shares
May 20, 2024 06:03AM Man Group PLC : Form 8.3 - Tyman plc
May 20, 2024 06:00AM Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
View Older Stories